# OnCo record paper-cercek-nonoperative-management-mismatch-repair-deficient-tumours-nejm-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cercek-nonoperative-management-mismatch-repair-deficient-tumours-nejm-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cercek-nonoperative-management-mismatch-repair-deficient-tumours-nejm-2025" ;
  schema:name "Nonoperative management of mismatch repair-deficient tumors"@en ;
  schema:description "The extension of the rectal dostarlimab result to every organ: 49 of 49 rectal cancers and 35 of 54 other early-stage mismatch repair-deficient cancers disappeared on six months of one drug, and 82 patients avoided surgery altogether."@en ;
  schema:url <https://onco.cc/key-papers/paper-cercek-nonoperative-management-mismatch-repair-deficient-tumours-nejm-2025/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2404512>, <https://pubmed.ncbi.nlm.nih.gov/40293177/>, <https://europepmc.org/article/MED/40293177> ;
  onco:tag "colorectal-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2404512> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Cercek A, Foote MB, Rousseau B, et al." ;
  onco:related <https://onco.cc/key-papers/paper-cercek-dmmr-rectal-nejm-2022/>, <https://onco.cc/key-papers/paper-niche-2-neoadjuvant-colon-nejm-2024/>, <https://onco.cc/key-papers/paper-garcia-aguilar-opra-organ-preservation-jco-2022/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/targets/mmr/>, <https://onco.cc/terms/organ-preservation/>, <https://onco.cc/terms/clinical-complete-response/>, <https://onco.cc/terms/complete-response/> ;
  onco:trials <https://onco.cc/trials/azur-1/> ;
  onco:people <https://onco.cc/people/andrea-cercek/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
